Contergan Victim Wins Against Former Board Member of the Contergan Foundation

Food and Healthcare Press Releases Thursday June 8, 2017 09:32
COLOGNE, Germany--8 Jun--PRNewswire/InfoQuest

In the lawsuit between the plaintiff, Contergan (thalidomide) victim Andreas Meyer, and the defendant and former Board member of the Contergan Foundation, Attorney Karl Schucht, the Bonn Regional Court came to a judgement on 10.5.2017. The judgement is not yet final. The case concerns the question of possible collaboration between Gruenenthal and the Federal German Contergan Foundation.

Meyer was and will be represented by Prof. Dr. Jan Hegemann from the law firm Raue Rechtsanwalte LLP in Berlin.
Please refer the full press release dated 08.06.2017 at:
You can read the judgement and further information at the following link:
Federation of Thalidomide Sufferers and Gruenenthal Victims
c/o Mr Andreas Meyer (Chairman)
Dohmengasse 7
50829 Koln
Mobile: +49 (0)172 / 2905974
Source: Federation of Thalidomide Sufferers and Gruenenthal Victims

Latest Press Release

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their...

FDI Global Survey Shows Children are not Getting Dental Check-ups Early Enough

On the occasion of World Oral Health Day, FDI World Dental Federation asked parents around the world how they cared for their children's oral health growing up and the responses suggest room for improvement. Maintaining a healthy mouth is crucial to...

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia...

Johnson Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan,...

Biotherm Hosts the First Biotherm Healing Summit

Biotherm hosted the first "Biotherm Healing Summit" on March 7. A symposium on the theme of skin & healing, focusing on major research that has evidenced the link between micro-organisms and skin health. Unveiling Life PlanktonTM, the healing...

Related Topics